GlassScriptPhysician profile
Grant Douglas Langhofer
NPI 1477114320
$652.04
in general payments reported to CMS, 2019-2025
10 companies · $84.94 in 2025
The $84.94 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $35.89 · 2022: $241 · 2023: $48.06 · 2024: $243 · 2025: $84.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $376.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $375.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ipsen Biopharmaceuticals, INC | $168.83 | 2022 | |
| Nevro Corp. | $144.43 | 2024 | Senza |
| Abbvie INC. | $87.14 | 2022-2023 | |
| Globus Medical, INC. | $58.75 | 2025 | Senza |
| Spr Therapeutics, INC | $51.21 | 2024 | Sprint Pns System |
| Medtronic, INC. | $47.87 | 2022-2024 | Synchromedii |
| Abbott Laboratories | $31.73 | 2024 | Proclaim |
| Fidia Pharma USA INC. | $26.19 | 2025 | Hymovis |
| Ge Healthcare | $18.85 | 2021 | |
| Boston Scientific Corporation | $17.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grant Langhofer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.